Fundraising FoxLaura A. Lane
Former Associate at Advent Life Sciences
Oxford, United Kingdom
Writes $25K – $5M checks · typically $1M
Find your path to Laura
92 people in our graph can introduce you to Laura.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Katherine High to introduce you to Laura
You →Katherine · together at VirionHealth Ltd (2018) →Laura
Ask Jamie Chen to introduce you to Laura
You →Jamie · together at Aston Particle Technologies Ltd. →Laura
Ask Sam Okafor to introduce you to Laura
You →Sam · 4 people · together at Advent Life Sciences →Laura
Sign up to find every way you can get introduced to Laura
- Your email: the people you already email who know Laura
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Laura
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Laura A. Lane is Vice President and Europe Head of Lilly Ventures at Eli Lilly and Company, where she focuses on venture investment in life sciences. She has held roles spanning pharmaceutical consulting, business development, and executive leadership, with experience in investment raising, partnerships, diligence, and board management. Lane serves as a Non-Executive Director at the BioIndustry Association.
Experience
- BioIndustry Association (BIA)NEDcurrent2024 — presentUnited Kingdom
- Eli Lilly and CompanyVice President - Lilly Ventures (Head of Europe)current2022 — present
- Collaborative Community against Coronavirus CICMember Board of Directorscurrent2022 — presentGreater London, England, United Kingdom
- Advent Life SciencesPrincipal2021 — 2022London, UK
- Advent Life SciencesAssociate2019 — 2021London Area, United Kingdom
- ConsultantStrategy, Business & Corporate Development2018 — 2022
- Aston Particle Technologies Ltd.Interim CEO2018 — 2019West Midlands, England, United Kingdom
- RefeynInterim COO2018 — 2019Greater Oxford Area
- VirionHealth LtdCo-founder, Director & Chief Operating Officer2015 — 2018www.virionhealth.com
- Warwick VenturesBusiness Development2012 — 2017
- Black Swan Analysis LtdAnalyst, Analysis & Forecasting2010 — 2012
- University of OxfordVisiting Researcher2010
Skills & more
+12 more
Drug DiscoveryBiopharmaceuticalsImmunologyInfectious DiseasesResearchMarket AnalysisGenomicsBiochemistryMass SpectrometryNegotiationKnowledge TransferManagementFrom Laura's professional profile.
Frequently asked questions
- Who is Laura A. Lane?
- Laura A. Lane is Vice President and Europe Head of Lilly Ventures at Eli Lilly and Company, where she focuses on venture investment in life sciences. She has held roles spanning pharmaceutical consulting, business development, and executive leadership, with experience in investment raising, partnerships, diligence, and board management. Lane serves as a Non-Executive Director at the BioIndustry Association.
- What check size does Laura A. Lane write?
- Laura A. Lane typically writes checks of $25K – $5M.
- Where did Laura A. Lane go to school?
- Laura A. Lane studied at University of Cambridge (PhD, Biophysics, Structural Biology); University of Cambridge (MSci MA (Cantab), Natural Science (Chemistry)).
Same school
Also attended University of Cambridge1,682
+ 1,676 more
Shared employers
Also worked at Aston Particle Technologies Ltd.1
Also worked at Refeyn4
Also worked at VirionHealth Ltd1
Also worked at University of Oxford235
+ 229 more